Liletta IUD

Showing 17-24 of 24 results

Research roundup: February 2021 edition

Comparable effectiveness of Levonorgestrel and copper IUDs as emergency contraception, use of the Natural Cycles app for fertility awareness contraceptive method, transcutaneous electrical nerve stimulation as highly effective pain management in medication abortion care, and more.

Research roundup: November 2020 edition

Improved patient satisfaction with the implementation of One Key Question in primary care and OB/GYN care settings, increasing access to STI screening for adolescents and young adults, the need to improve contraceptive care for patients with a history of intimate partner violence, and more.

Research roundup: October 2020 edition

IUD use and a demonstrated decreased risk of ovarian cancer, salpingectomy vs. tubal ligation for sterilization, benefits of non-medical treatment options for recurrent bacterial vaginosis, and more.

Research roundup: November 2019 edition

The ACOG Committee Opinion’s support for over-the-counter hormonal contraception, efficacy of intracervical blocks for pain management during levonorgestrel IUD placement, studies on the mechanism of function of ulipristal acetate, and more.

Exciting News—LILETTA now approved for use up to 8 years!

The FDA has extended approval of LILETTA IUDs for up to 6 years of use, research shows they are safe and effective for up to 7 years.

What makes the Liletta IUD different from Mirena?

Here’s what you and your patients should know about these two (very similar) hormonal IUDs.

Who is at increased risk of IUD expulsion?

New research holds some surprises about who’s at highest risk of expelling an IUD.

IUDs, STIs, and PID: What’s the deal?

Contrary to popular myth, modern IUDs don't cause pelvic inflammatory disease (PID).
  • Previous
  • 1
  • 2
  • 3(current)
  • Next